Fusion oncogenes
- 1 June 2005
- journal article
- editorial
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 15 (3) , 159-161
- https://doi.org/10.1016/j.semcancer.2005.01.001
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic SyndromeNew England Journal of Medicine, 2003
- Inhibition of CHOP translation by a peptide encoded by an open reading frame localized in the chop 5'UTRNucleic Acids Research, 2001
- TEL-JAK2 transgenic mice develop T-cell leukemiaBlood, 2000
- The Mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesisThe EMBO Journal, 1999
- The PEBP2 β MYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasiaProceedings of the National Academy of Sciences, 1998
- Translocations, cancer and the puzzle of specificityNature Genetics, 1998
- Altered Myeloid Development and Acute Leukemia in Transgenic Mice Expressing PML-RARα Under Control of Cathepsin G Regulatory SequencesBlood, 1997
- Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic miceCell, 1993
- Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcomaNature, 1993
- Ph-positive Leukemia: A Transgenic Mouse ModelLeukemia & Lymphoma, 1993